These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22711683)

  • 1. Impact of intraoral stent on the side effects of radiotherapy for oral cancer.
    Verrone JR; Alves Fde A; Prado JD; Boccaletti KW; Sereno MP; Silva ML; Jaguar GC
    Head Neck; 2013 Jul; 35(7):E213-7. PubMed ID: 22711683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of an intraoral stent in decreasing the irradiation dose to oral healthy tissue: dosimetric and clinical features.
    Verrone JR; Alves FA; Prado JD; Marcicano Ad; de Assis Pellizzon AC; Damascena AS; Jaguar GC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Nov; 118(5):573-8. PubMed ID: 25442494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using a reduced spot size for intensity-modulated proton therapy potentially improves salivary gland-sparing in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e313-9. PubMed ID: 21708427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensity-modulated radiotherapy for head and neck cancer.
    Caglar HB; Allen AM
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):425-31. PubMed ID: 17679916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sparing the parotid glands and surgically transferred submandibular gland with helical tomotherapy in post-operative radiation of head and neck cancer: a planning study.
    Saibishkumar EP; Jha N; Scrimger RA; MacKenzie MA; Daly H; Field C; Fallone G; Parliament MB
    Radiother Oncol; 2007 Oct; 85(1):98-104. PubMed ID: 17923162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential benefits of scanned intensity-modulated proton therapy versus advanced photon therapy with regard to sparing of the salivary glands in oropharyngeal cancer.
    van de Water TA; Lomax AJ; Bijl HP; de Jong ME; Schilstra C; Hug EB; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1216-24. PubMed ID: 20732761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands.
    Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M
    Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scintigraphic assessment of salivary function after intensity-modulated radiotherapy for head and neck cancer: correlations with parotid dose and quality of life.
    Chen WC; Lai CH; Lee TF; Hung CH; Liu KC; Tsai MF; Wang WH; Chen H; Fang FM; Chen MF
    Oral Oncol; 2013 Jan; 49(1):42-8. PubMed ID: 22854066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence in region of spared parotid gland after definitive intensity-modulated radiotherapy for head and neck cancer.
    Cannon DM; Lee NY
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):660-5. PubMed ID: 18037580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive planning in intensity-modulated radiation therapy for head and neck cancers: single-institution experience and clinical implications.
    Ahn PH; Chen CC; Ahn AI; Hong L; Scripes PG; Shen J; Lee CC; Miller E; Kalnicki S; Garg MK
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):677-85. PubMed ID: 20619553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tongue-out versus tongue-in position during intensity-modulated radiotherapy for base of tongue cancer: Clinical implications for minimizing post-radiotherapy swallowing dysfunction.
    Kil WJ; Kulasekere C; Hatch C; Bugno J; Derrwaldt R
    Head Neck; 2017 Aug; 39(8):E85-E91. PubMed ID: 28475284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computed tomography number changes observed during computed tomography-guided radiation therapy for head and neck cancer.
    Feng M; Yang C; Chen X; Xu S; Moraru I; Lang J; Schultz C; Li XA
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1041-7. PubMed ID: 25832695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring dosimetric impact of weight loss with kilovoltage (kV) cone beam CT (CBCT) during parotid-sparing IMRT and concurrent chemotherapy.
    Ho KF; Marchant T; Moore C; Webster G; Rowbottom C; Penington H; Lee L; Yap B; Sykes A; Slevin N
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e375-82. PubMed ID: 22197229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased radiation doses to tongue with "stick-out" tongue position over neutral tongue position in head and neck cancer patients who refused or could not tolerate an intraoral device (bite-block, tongue blade, or mouthpiece) due to trismus, gag reflex, or discomfort during intensity-modulated radiation therapy.
    Kil WJ; Kulasekere C; Derrwaldt R; Bugno J; Hatch C
    Oncotarget; 2016 Aug; 7(33):53029-53036. PubMed ID: 27447973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
    Roach MC; Turkington TG; Higgins KA; Hawk TC; Hoang JK; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):321-6. PubMed ID: 21030160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of the initial volume of parotid glands in xerostomia for patients with head and neck cancers treated with IMRT.
    Nishimura Y; Nakamatsu K; Shibata T; Kanamori S; Koike R; Okumura M; Suzuki M
    Jpn J Clin Oncol; 2005 Jul; 35(7):375-9. PubMed ID: 15976068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.
    Vergeer MR; Doornaert PA; Rietveld DH; Leemans CR; Slotman BJ; Langendijk JA
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):1-8. PubMed ID: 19111400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Tu WY; Kirwan J; Mendenhall WM
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1479-87. PubMed ID: 20934262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.